CHOLESTEROL ABSORPTION INHIBITOR (AZETIDINONE) AND OMEGA 3 FATTY ACIDS (EPA, DHA, DPA) FOR THE REDUCTION OF CHOLESTEROL AND FOR THE REDUCTION OF CARDIOVASCULAR EVENTS - Patent 2675442

(19)

(11)

EP 2 675 442 A1

(12)

(43)	Date of publication:
	25.12.2013 Bulletin 2013/52

(21)	Application number: 12705588.7

(22)	Date of filing: 14.02.2012

(51)

International Patent Classification (IPC):

A61K 31/202^(2006.01)
A61P 9/00^(2006.01)

A61K 45/06^(2006.01)
A61K 31/397^(2006.01)

(86)	International application number:
	PCT/US2012/025003

(87)	International publication number:
	WO 2012/112511 (23.08.2012 Gazette 2012/34)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

16.02.2011 US 201161457268 P

(71)	Applicant: Pivotal Therapeutics, Inc.
	Woodbridge, Ontario L4H 0S5 (CA)

(72)	Inventors:
	JACKOWSKI, George Kettleby, Ontario L0G 1J0 (CA) MACSWEENEY, Rachelle Kettleby, Ontario L0G 1J0 (CA) SHAIKH, Nisar Mississauga, Ontario L5V 1B5 (CA) YANTHA, Jason Brampton, Ontario L6Y 1T2 (CA) SCHINI-KERTH, Valerie 67117 Fessenheim-le-Bas (FR)

(74)	Representative: Kremer, Simon Mark et al
	Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS London EC2V 8AS (GB)

(54)	CHOLESTEROL ABSORPTION INHIBITOR (AZETIDINONE) AND OMEGA 3 FATTY ACIDS (EPA, DHA, DPA) FOR THE REDUCTION OF CHOLESTEROL AND FOR THE REDUCTION OF CARDIOVASCULAR EVENTS